Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension
- 1 October 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 105 (10), 2283-2290
- https://doi.org/10.1097/tp.0000000000003490
Abstract
Background: Portopulmonary hypertension (POPH) is the presence of pulmonary arterial (PA) hypertension in patients with portal hypertension and is associated with significant morbidity and mortality. In a cohort of POPH patients, we describe the clinical outcomes of POPH patients who underwent liver transplantation (LT). Methods: Retrospectively collected data from a prospectively assembled cohort of all consecutive POPH adults evaluated in three transplant centers from 1996 to 2019. Results: From a cohort of 228 POPH patients, 50 patients underwent LT. Significant hemodynamic improvement after PA-targeted therapy was observed, with 58% receiving only monotherapy pre-transplant. After LT, 21 (42%) patients were able to discontinue and remained off PA-targeted therapy. The 1, 3, and 5 year unadjusted survival rates after LT were 72%, 63% and 60%, respectively. An elevated pulmonary vascular resistance (PVR) before LT was associated with worse survival rate (HR 1.91, 95% CI 1.07-3.74, p=0.04). No survival difference was observed in those granted MELD exception or transplants performed before or after the year 2010. Conclusion: Significant number of POPH patients discontinued PA-targeted therapy after LT. Higher PVR before LT was associated with worse survival, as was monotherapy use. Despite effective PA-targeted therapies, POPH survival outcomes after LT in our cohort were modest and may reflect the need for more aggressive therapy.This publication has 28 references indexed in Scilit:
- Mild to moderate pulmonary hypertension in liver transplantationJournal of Surgical Research, 2013
- Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: An analysis of cutoff valuesLiver Transplantation, 2013
- Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertensionLiver Transplantation, 2012
- Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment SubgroupsAmerican Journal of Transplantation, 2008
- The Impact of Treatment of Portopulmonary Hypertension on Survival Following Liver TransplantationAmerican Journal of Transplantation, 2007
- Portopulmonary hypertension: Results from a 10-year screening algorithmJournal of Hepatology, 2006
- Successful Liver Transplantation Following Medical Management of Portopulmonary Hypertension: A Single-Center SeriesAmerican Journal of Transplantation, 2006
- Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant databaseLiver Transplantation, 2004
- Pulmonary Hemodynamics and Perioperative Cardiopulmonary-Related Mortality in Patients With Portopulmonary Hypertension Undergoing Liver TransplantationLiver Transplantation, 2000
- Accuracy of Doppler Echocardiography in the Assessment of Pulmonary Hypertension in Liver Transplant CandidatesLiver Transplantation, 2000